Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program

Catherine Kim, Elizabeth Barrett-Connor, John F. Randolph, Shengchun Kong, Bin Nan, Kieren Mather, Sherita H. Golden

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives To examine whether estrogen use potentiates weight loss interventions via sex steroid levels and whether endogenous sex steroid levels predict response to weight loss interventions among women not using estrogen. Methods The Diabetes Prevention Program randomized overweight or obese dysglycemic participants to lifestyle change with the goals of weight reduction of >7% of initial weight and 150 minutes per week of exercise, metformin, or placebo. In this secondary analysis, we examined sex steroid levels and reductions in weight and waist circumference (WC) among postmenopausal women using (n = 324) and not using (n = 382) oral estrogen. Results Estrogen users and nonusers randomized to lifestyle change and metformin both lost significant amounts of weight compared to placebo. Reductions in weight and WC over 1 year associated with randomization arm were not associated with baseline sex steroid levels among estrogen users or nonusers. Conclusions Among estrogen users, baseline sex steroids were not associated with reductions in weight or WC, suggesting that exogenous estrogen does not potentiate weight loss by altering sex steroids. Among nonestrogen users, baseline sex steroids were not associated with reductions in weight or WC.

Original languageEnglish
Pages (from-to)882-887
Number of pages6
JournalObesity
Volume22
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Weight Loss
Steroids
Estrogens
Waist Circumference
Metformin
Life Style
Placebos
Weights and Measures
Random Allocation
Exercise

ASJC Scopus subject areas

  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program. / Kim, Catherine; Barrett-Connor, Elizabeth; Randolph, John F.; Kong, Shengchun; Nan, Bin; Mather, Kieren; Golden, Sherita H.

In: Obesity, Vol. 22, No. 3, 2014, p. 882-887.

Research output: Contribution to journalArticle

Kim, Catherine ; Barrett-Connor, Elizabeth ; Randolph, John F. ; Kong, Shengchun ; Nan, Bin ; Mather, Kieren ; Golden, Sherita H. / Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program. In: Obesity. 2014 ; Vol. 22, No. 3. pp. 882-887.
@article{9f5b07e95f504f87bf98edbfe410e3b9,
title = "Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program",
abstract = "Objectives To examine whether estrogen use potentiates weight loss interventions via sex steroid levels and whether endogenous sex steroid levels predict response to weight loss interventions among women not using estrogen. Methods The Diabetes Prevention Program randomized overweight or obese dysglycemic participants to lifestyle change with the goals of weight reduction of >7{\%} of initial weight and 150 minutes per week of exercise, metformin, or placebo. In this secondary analysis, we examined sex steroid levels and reductions in weight and waist circumference (WC) among postmenopausal women using (n = 324) and not using (n = 382) oral estrogen. Results Estrogen users and nonusers randomized to lifestyle change and metformin both lost significant amounts of weight compared to placebo. Reductions in weight and WC over 1 year associated with randomization arm were not associated with baseline sex steroid levels among estrogen users or nonusers. Conclusions Among estrogen users, baseline sex steroids were not associated with reductions in weight or WC, suggesting that exogenous estrogen does not potentiate weight loss by altering sex steroids. Among nonestrogen users, baseline sex steroids were not associated with reductions in weight or WC.",
author = "Catherine Kim and Elizabeth Barrett-Connor and Randolph, {John F.} and Shengchun Kong and Bin Nan and Kieren Mather and Golden, {Sherita H.}",
year = "2014",
doi = "10.1002/oby.20527",
language = "English",
volume = "22",
pages = "882--887",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program

AU - Kim, Catherine

AU - Barrett-Connor, Elizabeth

AU - Randolph, John F.

AU - Kong, Shengchun

AU - Nan, Bin

AU - Mather, Kieren

AU - Golden, Sherita H.

PY - 2014

Y1 - 2014

N2 - Objectives To examine whether estrogen use potentiates weight loss interventions via sex steroid levels and whether endogenous sex steroid levels predict response to weight loss interventions among women not using estrogen. Methods The Diabetes Prevention Program randomized overweight or obese dysglycemic participants to lifestyle change with the goals of weight reduction of >7% of initial weight and 150 minutes per week of exercise, metformin, or placebo. In this secondary analysis, we examined sex steroid levels and reductions in weight and waist circumference (WC) among postmenopausal women using (n = 324) and not using (n = 382) oral estrogen. Results Estrogen users and nonusers randomized to lifestyle change and metformin both lost significant amounts of weight compared to placebo. Reductions in weight and WC over 1 year associated with randomization arm were not associated with baseline sex steroid levels among estrogen users or nonusers. Conclusions Among estrogen users, baseline sex steroids were not associated with reductions in weight or WC, suggesting that exogenous estrogen does not potentiate weight loss by altering sex steroids. Among nonestrogen users, baseline sex steroids were not associated with reductions in weight or WC.

AB - Objectives To examine whether estrogen use potentiates weight loss interventions via sex steroid levels and whether endogenous sex steroid levels predict response to weight loss interventions among women not using estrogen. Methods The Diabetes Prevention Program randomized overweight or obese dysglycemic participants to lifestyle change with the goals of weight reduction of >7% of initial weight and 150 minutes per week of exercise, metformin, or placebo. In this secondary analysis, we examined sex steroid levels and reductions in weight and waist circumference (WC) among postmenopausal women using (n = 324) and not using (n = 382) oral estrogen. Results Estrogen users and nonusers randomized to lifestyle change and metformin both lost significant amounts of weight compared to placebo. Reductions in weight and WC over 1 year associated with randomization arm were not associated with baseline sex steroid levels among estrogen users or nonusers. Conclusions Among estrogen users, baseline sex steroids were not associated with reductions in weight or WC, suggesting that exogenous estrogen does not potentiate weight loss by altering sex steroids. Among nonestrogen users, baseline sex steroids were not associated with reductions in weight or WC.

UR - http://www.scopus.com/inward/record.url?scp=84895835665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895835665&partnerID=8YFLogxK

U2 - 10.1002/oby.20527

DO - 10.1002/oby.20527

M3 - Article

VL - 22

SP - 882

EP - 887

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 3

ER -